Great Bay Bio Closes Nearly USD10M Series A Funding

Great Bay Bio, a Hong Kong-based high-tech enterprise dedicated to applying artificial intelligence and other technologies in CMC bioprocessing, completed a near USD10M Series A funding. The round was led by Proxima Ventures with participation from many new and existing institutional investors.

Read more:


在 建立網站或網誌

向上 ↑

%d 位部落客按了讚: